Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10545-014-9716-5PMID 24789341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum: Phenylalanine hydroxylase deficiency: Diagnosis and management guideline (Genetics in Medicine (2014) 16:2 (188-200) DOI:10.1038/gim.2013.157)

  2014cited by this paper
• Phenylalanine hydroxylase deficiency: diagnosis and management guideline

  2013cited by this paper
• Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias

  2013cited by this paper
• Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis

  2013cited by this paper
• Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria.

  2012cited by this paper
• Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies and prediction of long-term responders.

  2012cited by this paper
• Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation

  2012cited by this paper
• The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response.

  2011cited by this paper
• A case of maternal phenylketonuria syndrome presenting with unilateral renal agenesis.

  2011cited by this paper
• German Maternal Phenylketonuria Study

  2009cited by this paper
• Maternal tetrahydrobiopterin deficiency: The course of two pregnancies and follow-up of two children in a mother with 6-pyruvoyl-tetrahydropterin synthase deficiency

  2009cited by this paper
• Phenylalanine tolerance in three phenylketonuric women pregnant with fetuses of different genetic PKU status

  2009cited by this paper
• Maternal Phenylketonuria and Tetrahydrobiopterin

  2008cited by this paper
• Molecular genetics of tetrahydrobiopterin‐responsive phenylalanine hydroxylase deficiency

  2008cited by this paper
• Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

  2007cited by this paper
• The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency

  2006cited by this paper
• Tetrahydrobiopterin and maternal PKU.

  2005cited by this paper
• Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.

  2005cited by this paper
• Maternal phenylketonuria: the French survey

  2004cited by this paper
• The Maternal Phenylketonuria International Study: 1984-2002.

  2003cited by this paper
• Pregnancy experiences in the woman with mild hyperphenylalaninemia.

  2003cited by this paper
• Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.

  2003cited by this paper
• Chemistry and Biology of Pteridines and Folates

  2002cited by this paper
• Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.

  2002cited by this paper
• [Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients].

  2002cited by this paper
• Repérage des hyperphénylalaninémies par déficit en tétrahydrobioptérine

  2002cited by this paper
• Maternal phenylketonuria: an international study.

  2000cited by this paper
• The international collaborative study of maternal phenylketonuria: status report 1998

  2000cited by this paper
• The international collaborative study of maternal phenylketonuria: status report 1994

  1994cited by this paper
• Chemistry and Biology of Pteridines and Folates

  1993cited by this paper
• Experimental research on a new treatment for maternal phenylketonuria(PKU).

  1993cited by this paper
• Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

  1984cited by this paper
• Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

  1983cited by this paper
• Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

  1980cited by this paper

• The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening

  2026cites this paper
• Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU‐MOMs sub‐registries

  2024cites this paper
• Inborn Errors of Metabolism and Pregnancy.

  2024cites this paper
• Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG).

  2023cites this paper
• The treatment of biochemical genetic diseases: From substrate reduction to nucleic acid therapies.

  2023cites this paper
• Genetic etiology and clinical challenges of phenylketonuria

  2022cites this paper
• Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre

  2021cites this paper
• Maternal Genetic Disorders That Affect Fetal Health

  2021cites this paper
• Phenylketonuria

  2021cites this paper
• Tetrahydrobiopterin in phenylketonuria: Who can benefit?

  2020cites this paper
• [Phenylketonuria, from diet to gene therapy].

  2020cites this paper
• First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child

  2019cites this paper
• Phenylketonuria

  2019cites this paper
• International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.

  2019cites this paper
• Treatment With Tetrahydrobiopterin Improves White Matter Maturation in a Mouse Model for Prenatal Hypoxia in Congenital Heart Disease

  2019cites this paper
• Nutrition and medical support during pregnancy and lactation in women with inborn errors of intermediary metabolism disorders (IEMDs)

  2019cites this paper
• Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders

  2018cites this paper
• Impact of pregnancy on inborn errors of metabolism

  2018cites this paper
• Successful control of maternal phenylketonuria by tetrahydrobiopterin

  2018cites this paper
• The phenylketonuria patient: A recent dietetic therapeutic approach

  2018cites this paper
• Reproductive experience of women living with phenylketonuria

  2018cites this paper
• Tetrahydrobipterin-responsive phenylalanine hydroxylase deficiency

  2018cites this paper
• Partial hydatidiform mole in a phenylketonuria patient treated with sapropterin dihydrochloride

  2017cites this paper
• The complete European guidelines on phenylketonuria: diagnosis and treatment

  2017cites this paper
• [Psychomotor retardation and intermitent convulsions for 8 months in an infant].

  2016influential citation
• The challenges of managing coexistent disorders with phenylketonuria: 30 cases.

  2015cites this paper
• Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran

  2015cites this paper
• The Kuvan(®) Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to Sapropterin.

  2015cites this paper
• Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience

  2015cites this paper